Nuo Therapeutics's Cash & cash equivalent grew by 196.39 % in the Q2 2026 sequentially, faster than Current Liabilities, this led to improvement in Nuo Therapeutics's Quick Ratio to 0.29, Quick Ratio remained below Nuo Therapeutics, Inc. average.

Within Medical Laboratories industry 21 other companies have achieved higher Quick Ratio than Nuo Therapeutics in second quarter 2026. While Quick Ratio total ranking in the second quarter 2026 has deteriorated compared to the prior quarter from to 3101.

Explain Quick Ratio?
How much Cash & cash equivalents CMXI�s has?
What are CMXI�s Current Liabilities?

Select the Comparisons :

None ▼

Select the Ratio:

Quick Ratio ▼

None ▼

Quick Ratio ▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

CMXI Quick Ratio	(Jun 30 2026) Q2	(Jun 30 2021) Q2	(Mar 31 2021) Q1	(Dec 31 2020) Q4	(Sep 30 2020) Q3
Y / Y Current Liabilities Change	54.75 %	-32.99 %	-33.1 %	-53.33 %	-83.23 %
Y / Y Cash & cash equivalent Change	-	-	1304.46 %	-32.83 %	-
Quick Ratio MRQ	0.29	0.23	0.24	0.24	-
CMXI's Total Ranking	# 3101	#	#	#	#
Seq. Current Liabilities Change	132.36 %	0.35 %	0.24 %	-33.79 %	0.62 %
Seq. Cash & cash equivalent Change	196.39 %	-3.62 %	-2.54 %	-	-

Quick Ratio second quarter 2026 Company Ranking
Within:	No.
Medical Laboratories Industry	# 22
Healthcare Sector	# 581
Overall Market	# 3101

Quick Ratio Statistics
High	Average	Low
2.89	0.99	0.01
(Sep 30 2014)		(Mar 31 2020)

Financial Statements
Nuo Therapeutics's Current Liabilities	$ 2 Millions	Visit CMXI's Balance sheet
Nuo Therapeutics's Cash & cash equivalent	$ 0 Millions	Visit CMXI's Balance sheet
Source of CMXI's Sales		Visit CMXI's Sales by Geography

Cumulative Nuo Therapeutics's Quick Ratio

CMXI's Quick Ratio for the trailling 12 Months

CMXI Quick Ratio	(Jun 30 2026) 12 Months	(Jun 30 2021) 12 Months	(Mar 31 2021) 12 Months	(Dec 31 2020) 12 Months	(Sep 30 2020) 12 Months
Y / Y Current Liabilities TTM Growth	-19.65 %	-68.07 %	-78.32 %	-84.18 %	-85.33 %
Y / Y Cash & cash equivalent TTM Growth	265.66 %	-95.59 %	-98.96 %	-99.69 %	-99.6 %
Quick Ratio TTM	0.26	0.16	0.1	0.05	0.06
Total Ranking TTM	# 3737	#	#	#	#
Seq. Current Liabilities TTM Growth	18.3 %	-9.88 %	-9 %	-17.18 %	-52.99 %
Seq. Cash & cash equivalent TTM Growth	95.54 %	47.57 %	84.65 %	-31.37 %	-97.64 %

Quick ratio ranking by company, industry and sector >> Back to CMXI Financial Strength Comparisons >> Go to Compare CMXI Quick Ratio to its Competitors

On the trailing twelve months basis CMXI Cash & cash equivalent more than doubled by 196.39 % in Q2 2026 year on year, faster than Current Liabilities, this led to increase in in Nuo Therapeutics's Quick Ratio to 0.26, Quick Ratio remained below CMXI average.
Quick Ratio is the average cumulative value over the last four quarters.

Among companies operating within Medical Laboratories industry 20 other companies have achieved higher Quick Ratio than Nuo Therapeutics. While Quick Ratio total ranking has deteriorated compared to the previous twelve months ending in the second quarter 2021 from to 3737.

Explain Quick Ratio?
How much Cash & cash equivalents CMXI�s has?
What are CMXI�s Current Liabilities?

TTM Quick Ratio Company Ranking
Within:	No.
Within the Medical Laboratories Industry	# 21
Healthcare Sector	# 474
Within the Market	# 3737

trailing twelve months Quick Ratio Statistics
High	Average	Low
1.86	1.29	0.58
(Mar 31 2013)		(Mar 31 2014)

Companies with similar Quick Ratio in the quarter ending Jun 30 2026, within Medical Laboratories Industry	Quick Ratio	Jun 30 2026 MRQ Cash & cash equivalent	Jun 30 2026 MRQ Current Liabilities
Ispecimen inc	0.43	$ 4.426 Millions	$ 10.196 Millions
Quest Diagnostics Inc	0.40	$ 720.000 Millions	$ 1,788.000 Millions
Lumexa Imaging Holdings Inc	0.39	$ 69.705 Millions	$ 178.355 Millions
Medpace Holdings Inc	0.35	$ 502.688 Millions	$ 1,435.429 Millions
American Shared Hospital Services	0.30	$ 6.761 Millions	$ 22.424 Millions
Nuo Therapeutics, Inc.	0.29	$ 0.449 Millions	$ 1.554 Millions
Icon Plc	0.24	$ 930.885 Millions	$ 3,934.665 Millions
Fortrea Holdings Inc	0.17	$ 168.600 Millions	$ 963.700 Millions
Charles River Laboratories International inc	0.17	$ 192.025 Millions	$ 1,134.746 Millions
Nrc Health	0.10	$ 3.327 Millions	$ 35.019 Millions
Onemednet Corporation	0.07	$ 0.358 Millions	$ 4.858 Millions
Labcorp Holdings Inc	0.07	$ 141.800 Millions	$ 2,124.600 Millions

Date modified: 2026-09-08T17:09:12+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.